UnitedHealth (UNH) CAO adds shares through dividend-equivalent RSU grant

Rhea-AI Filing Summary

UnitedHealth Group’s Chief Accounting Officer Dennis Andrew Stankiewicz reported a small equity-related acquisition through a Form 4. He received 50.590 shares of common stock as dividend equivalents on outstanding restricted stock units, at a stated price of $0.00 per share.

These dividend equivalents are subject to the same vesting and forfeiture terms as the underlying restricted stock units. Following this award, his directly held common stock position reported in the filing increased to 10,256.529 shares, indicating a routine, compensation-linked update rather than an open-market transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Stankiewicz Dennis Andrew

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	50.59	$0.00	--

Holdings After Transaction: Common Stock — 10,256.529 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares acquired: 50.590 shares Price per share: $0.00 per share Post-transaction holdings: 10,256.529 shares +2 more

5 metrics

Shares acquired 50.590 shares Dividend equivalents on restricted stock units, transaction on June 23, 2026

Price per share $0.00 per share Stated transaction price for dividend-equivalent shares

Post-transaction holdings 10,256.529 shares Directly held UnitedHealth Group common stock after the award

Transaction code A Grant, award, or other acquisition of common stock

Insider role Chief Accounting Officer Officer title of Dennis Andrew Stankiewicz

Key Terms

dividend equivalents, restricted stock units, Form 4, Common Stock, +1 more

5 terms

dividend equivalents financial

"Represents dividend equivalents paid on outstanding restricted stock units."

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

restricted stock units financial

"The dividend equivalents are subject to the same terms as the underlying restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 regulatory

"Please analyze the following financial content according to the instructions above. INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 05:37 PM Accepted by SEC EDGAR 06/25/2026 - 05:37 PM Learn about SEC filing dates

FAQ

What insider transaction did UNH Chief Accounting Officer report on this Form 4?

The Chief Accounting Officer reported acquiring 50.590 shares of UnitedHealth Group common stock. These came as dividend equivalents on existing restricted stock units, not through an open-market purchase, and were recorded at a stated price of $0.00 per share.

Were UnitedHealth Group (UNH) shares bought or sold on the open market in this Form 4?

No open-market trades occurred in this Form 4. The filing shows a grant of 50.590 dividend-equivalent shares tied to restricted stock units, reflecting compensation-related equity rather than discretionary buying or selling in the market.

How many UnitedHealth Group (UNH) shares does the insider hold after this transaction?

After the dividend-equivalent award, the insider’s directly held UnitedHealth Group common stock position reported in the filing is 10,256.529 shares. This total incorporates the additional 50.590 shares received through the grant and reflects the updated direct ownership.

What are dividend equivalents on restricted stock units for UNH insiders?

Dividend equivalents mirror cash dividends on shares underlying restricted stock units. For this UNH insider, they were paid as 50.590 additional shares and are subject to the same vesting and forfeiture terms as the underlying restricted stock units described in the footnote.

Is the UNH Form 4 transaction a routine compensation event?

Yes, the transaction reflects a routine compensation-related event. The 50.590 shares were issued as dividend equivalents on outstanding restricted stock units, and they vest or are forfeited under the same conditions as the underlying equity awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stankiewicz Dennis Andrew

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2026		A		50.59(1)	A	$0	10,256.529	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Dennis A. Stankiewicz	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)